SoylentNews is people
SoylentNews
A recall for EpiPens will now extend to Asia, Europe, North America, and South America:
Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.
The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies.
[Ed. Note: This recall is limited to some lot numbers distributed in late 2015 and early-to-mid 2016. More information at the US FDA website.]
This discussion has been archived.
No new comments can be posted.
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
Confess your sins to the Lord and you will be forgiven;
confess them to man and you will be laughed at.
-- Josh Billings
(Score: 2) by bob_super on Monday April 03 2017, @05:13PM
> run afoul of antitrust law as a result
Quake in your boots! A couple blue state AGs may start hinting at a decades-long process which might potentially result in a minor slap on the wrist!